Clinical Trial

Myriad™ Augmented Soft Tissue Reconstruction Registry

Study acronym: MASTRR
Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2022-02-08; most recent amendment 2026-07-13.
Trial Details
NCT Number NCT05243966
Lead Sponsor Aroa Biosurgery Limited
Conditions Abdominal Wound Dehiscence, Necrotizing Soft Tissue Infection, Lower Extremity Wound, Pilonidal Sinus, Anal Fistula, Hidradenitis Suppurativa, Pressure Injury
Enrollment 800 participants
Start Date 2022-01-10
Primary Completion 2028-01 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-15